Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin

Experimental Dermatology

Volumn 6, Issue 2, 1997, Pages 98-104

  Wood, Ladonna C ^a,b,c,d   Stalder, Anna K ^a,b,c,d   Liou, Amelie ^a,b,c,d   Campbell, Iain L ^a,b,c,d   Grunfeld, Carl ^a,b,c,d   Elias, Peter M ^a,b,c,d   Feingold, Kenneth R ^a,b,c,d  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

essential fatty acid deficiency; interleukin 1; RNase protection; tape stripping

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; EPIDERMIS; GENE EXPRESSION; MOUSE; NONHUMAN; NORTHERN BLOTTING; SKIN; SKIN PERMEABILITY;

ANIMALS; ANTIGENS, CD; BODY WATER; CYTOKINES; DIETARY FATS; EPIDERMIS; FATTY ACIDS, ESSENTIAL; GENE EXPRESSION REGULATION; LATEX; MALE; MICE; MICE, INBRED HRS; MICE, MUTANT STRAINS; OCCLUSIVE DRESSINGS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; SKIN;

EID: 0030943508     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1997.tb00154.x     Document Type: Article

References (20)

1. Wood L C, Jackson S M, Elias P M, Grunfeld C, Feingold K R. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992: 90(2): 482-487.
2. Tsai J C, Feingold K R, Crumrine D, Wood L C, Grunfeld C, Elias P M. Permeability barrier disruption alters the localization and expression of TNF alpha protein in the epidermis. Arch Dermatol Res 1994: 286: 242-248.
3. Wood L C, Feingold K R, Sequeira-Martin S M, Elias P M, Grunfeld C. Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp Dermatol 1994: 3: 56-60.
4. Nickoloff B J, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994: 30: 535-546.
5. Krueger J, Krane J, Carter D, Gottlieb A. Role of growth factors, cytokines and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990: 94: 135S-140S.
6. Wood L C, Elias P M, Sequeira-Martin S M, Grunfeld C, Feingold K R. Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 1994: 103: 834-838.
7. Proksch E, Holleran W M, Menon G K, Elias P M, Feingold K R. Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 1993: 128: 473-482.
8. Elias P, Holleran W, Menon G, Ghadially R, Williams M, Feingold K. Normal mechanisms and pathophysiology of epidermal permeability barrier homeostasis. Curr Opin Dermatol 1993: 231-237.
9. Kupper T S. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 1990: 86: 1783-1789.
10. Barker J N W N, Mitra R S, Griffiths L E M, Dixit V M, Nickoloff B J. Keratinocytes as initiators of inflammation. Lancet 1991: 337: 211-214.
11. Denda M, Wood L C, Emami S et al. Epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 1996: 288: 230-238.
12. Loetscher H, Steinmetz M, Lesslauer W. Tumor necrosis factor: receptors and inhibitors. Cancer Cells. Cold Spring Harbor, 1991: 3: 221-226.
13. Tartaglia L A, Goeddel D V. Two TNF receptors. Immunol Today 1992: 13: 151-153.
14. Tartaglia L A, Weber R F, Figari I S, Reynolds C, Palladino M A Jr, Goeddel D V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 1991: 88: 9292-9296.
15. Beutler B, van Huffel C. Unraveling function in the TNF ligand and receptor families. Science 1994: 264: 667-668.
16. Erickson S L, de Savvage F J, Kikly K et al. Decreased sensitivity to tumor necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994: 372: 560-563.
17. Trefzer U, Brockhaus M, Loetscher H et al. 55-kD tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J Invest Dermatol 1991: 97: 911-916.
18. Kristensen M, Chu C, Eedy D, Feldmann M, Brennan F, Breathnach S. Localization of tumor necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 1993: 94: 354-362.
19. DinarelloC A. Interleukin-1 and interleukin-1 antagonism. Blood 1991: 77: 1627-1652.
20. Sims J, March C J, Cosman D et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988: 241: 585-589.